Mater Research
Support Us
  • Home
  • About us
    • Mission and vision
    • Strategy
    • History
    • Executives
    • Executive Board
    • Research Advisory Board
    • Organisational structure
    • Partners and collaborators
    • Employment
    • Gender Equity Initiative
  • Our research
    • Research programs and groups
    • Biobanks
      • Gynaecological and Breast Cancer Biobank
      • David Serisier Respiratory Biobank
      • Mater Inflammatory Bowel Disease (IBD) Biobank
    • Participate in research at Mater
      • Participate in a clinical trial
      • Volunteer Consumer Representatives
      • Submit a Compliment or Complaint
  • Researchers
    • Our researchers
    • For researchers
      • Ethics and Governance
      • Mater Clinical Trials
      • Biobanks | Important information for researchers
      • Mater, TRI and UQ Quick Links
      • Submit a Compliment or Complaint
    • Mater Research award winners
    • Career track fellows
    • Sisters of Mercy Medals
  • Clinical Trials
    • For industry sponsors
  • Students
    • Current students
      • Student committee
    • Future students
      • Student Research Opportunities
      • Why study at Mater Research
      • Scholarships and Awards
      • Application Process
      • Register your interest for a Student Project
      • Student life
  • News
    • News
    • Publications
  • Support Us
  • Home
  • About us
    • Mission and vision
    • Strategy
    • History
    • Executives
    • Executive Board
    • Research Advisory Board
    • Organisational structure
    • Partners and collaborators
    • Employment
    • Gender Equity Initiative
  • Our research
    • Research programs and groups
    • Biobanks
      • Gynaecological and Breast Cancer Biobank
      • David Serisier Respiratory Biobank
      • Mater Inflammatory Bowel Disease (IBD) Biobank
    • Participate in research at Mater
      • Participate in a clinical trial
      • Volunteer Consumer Representatives
      • Submit a Compliment or Complaint
  • Researchers
    • Our researchers
    • For researchers
      • Ethics and Governance
      • Mater Clinical Trials
      • Biobanks | Important information for researchers
      • Mater, TRI and UQ Quick Links
      • Submit a Compliment or Complaint
    • Mater Research award winners
    • Career track fellows
    • Sisters of Mercy Medals
  • Clinical Trials
    • For industry sponsors
  • Students
    • Current students
      • Student committee
    • Future students
      • Student Research Opportunities
      • Why study at Mater Research
      • Scholarships and Awards
      • Application Process
      • Register your interest for a Student Project
      • Student life
  • News
    • News
    • Publications
  • Support Us
Home   Researchers   Our researchers
A/Prof Jake Begun

A/Prof Jake Begun

jake.begun@mater.org.au
+61 7 31632371
BioCurrent ResearchGeneral InformationRelated News

A/Prof Jake Begun

  • Group Leader - Inflammatory Bowel Diseases Research

A/Prof Jake Begun

A/Prof Jake Begun leads the Inflammatory Bowel Diseases (IBD) research group at Mater Research and is the director of Gastroenterology at Mater Hospital Brisbane. He is an Associate Professor at the University of Queensland School of Medicine. Jake’s translational research interests include dissecting the interplay of genetics, innate immunology and the gut microbiome to better understand the pathogenesis of IBD.  His clinical research focusses on the real-world effectiveness of therapeutics, the use of ultrasound to monitor disease activity, developing novel therapeutics for treating gut inflammation, and improving mental health outcomes in IBD.

Jake’s translational research group focuses on the pathogenesis and treatment of IBD, mucosal immunology and the microbiome. The lab is aiming to understand the contributions of genetic risk to alterations in the innate immune system and the interactions between the gut microbiome and the immune system that lead to pro and anti-inflammatory states. Jake is also heavily involved in clinical research and collaborating with clinicians from Mater and other hospitals to improve care for IBD patients, particularly in young adolescents and young adults who generally have a high burden of disease and associated conditions including anxiety and depression. He continues to maintain active collaborations with researchers at Harvard University and has formed new collaborations with researchers across Australia through his participation and leadership in the Australia and New Zealand IBD consortium.

Jake has authored over 70 scientific publications and has been very successful in competitive research funding, with funding success coming from Government, industry and philanthropic grants including the Viertel Clinical Research Award, a Ferring Innovation Grant and a Global Gut Health Grant. He serves on the Advisory Boards of several pharmaceutical and biotech companies including Abbvie, Janssen, Ferring, Pfizer, Takeda, BMS, Chiesi, Microba, and Suono.

“I pursued a career in medical research to advance the understanding of inflammatory diseases and improve the health of my patients. This has led me to pursue translational research projects in the lab, but also to learn from patient experiences through clinical research. In addition to my research endeavours, I maintain an active clinical practice, which is rewarding in itself, but also informs and inspires my research. I enjoy these complementary approaches to understanding and solving clinical problems and hope that my clinical practice and research activities will positively impact patients’ lives."

Professional memberships

  • Gastroenterological Society of Australia Inflammatory Bowel Disease Faculty - Chair
  • Australia and New Zealand IBD Consortium – Chair
  • Gastroenterology Network of Intestinal Ultrasonography – Treasurer and past President
  • Gastroenterological Society of Queensland – Organizing committee member
  • Gastroenterological Society of Australia – Board Member
  • International Bowel Ultrasound Group – Board member
  • European Crohn’s and Colitis Organization

Research Interests

  • Cancer Genetics - Oncology and Carcinogenesis 
  • Innate Immunity - Immunology 
  • Microbiology
  • Gastroenterology and Hepatology - Clinical Sciences

Current research

  • Group Leader - Inflammatory Bowel Diseases Research
  • Group Member - Allied Health Research
  • Program Member - Chronic and Integrated Care

Queensland woman Kelsie Dummètt is in the fight of her life against melanoma, and Mater Researchers are working to develop an immunotherapy to help patients like her.

13

Sep

Kelsie determined to beat melanoma after 14 operations

The evidence continues to grow about the importance of good gut bacteria for health, with Mater Researchers identifying 5 bacterial strains that suppress gut inflammation and IBD symptoms.

05

Jul

Gut bacteria potential key to IBD and colon cancer prevention

The Mater Inflammatory Bowel Disease (IBD) Research Group recently held their inaugural symposium to share novel research findings, and discuss innovation and the future of the group.

01

Sep

IBD Research group facilitate collaboration

Contact Us

07 3163 2555

Send an online enquiry

Level 3, Aubigny Place
Raymond Terrace
South Brisbane, Qld 4101

Mater Research

About us
Our research
Research programs
Clinical trials

Researchers
Our researchers
For researchers
News and events

Students
Current students
Future students
Support Us
Sitemap

Other Mater Sites

Corporate Website
Careers
Mater Cancer Care Centre
Mater Education
Mater Foundation
Mater Centre for Neurosciences

Mater Health and Wellness
Mater Mothers
Mater Online
Mater Pathology
Mater Pharmacy
Mater SafeQuest

© Mater Misericordiae Ltd . ACN 096 708 922